Recent Advances in MRI Based Volumetry and Morphometry for AD Diagnosis in Human

Author(s):
Admiraal-Behloul, F.; Ferrarini, L.; Milles, J.; Reiber, J.H.C. (0000-0002-0387-6417)
Published
2011
Publication type
Article / Letter to editor

Abstract

Alzheimer's disease (AD) is a progressive disease usually accompanied by regional atrophy that can be detected noninvasively using structural magnetic resonance imaging (MRI). An abundant literature has demonstrated the value of quantitative measurements of regional atrophy in AD, suggesting that MR based volumetry and morphometry could be valuable and useful in clinical practice. The aim of this paper is mainly to recall the most critical points to consider when using MRI for automated brain volumetry and morphometry and review briefly the main findings in the literature on brain volumetry and morphometry in AD.

Alzheimer's disease magnetic resonance imaging morphometric biomarkers MR-based morphometry MR-based volumetry volumetric biomarkers mild cognitive impairment white-matter hyperintensities voxel-based morphometry alzheimers-disease in-vivo magnetization-transfer corpus-callosum gray-matter probable ad 1.5 t
Date issued
2011-02-28
Language
English
Is part of
Current Medical Imaging Reviews (2011), Vol. 7, no. 1, p. 34-42
hdl
1887/110945
doi
10.2174/157340511794653450